Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

Advanced biliary tract carcinomas (BTCs) are often diagnosed at an advanced/metastatic stage and have a poor prognosis. The combination of gemcitabine and oxaliplatin (GEMOX) has shown promising activity in this setting. This international phase II study evaluated the efficacy and safety of GEMOX as...

詳細記述

保存先:
書誌詳細
主要な著者: André, T, Reyes-Vidal, J M, Fartoux, L, Ross, P, Leslie, M, Rosmorduc, O, Clemens, M R, Louvet, C, Perez, N, Mehmud, F, Scheithauer, W
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2008
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2538748/
https://ncbi.nlm.nih.gov/pubmed/19238628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604628
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料